Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Ulcerative Colitis: full-pipeline trial registry
45 of 123 indexed Ulcerative Colitis trials are currently recruiting.
Corpus placement: #97 of 28,707 conditions by registered trial count.
123 US clinical trials · 45 currently recruiting · #97 of 28,707 conditions by registered trial count
Ulcerative Colitis: 123 US clinical trials tracked, 45 recruiting.
Ulcerative Colitis is the subject of 123 registered US clinical trials on ClinicalTrials.gov, 45 of them currently open to new participants. 32 are in Phase 3-4 (later-stage) and 47 in Phase 1-2 (earlier-stage). The most active sponsor is Eli Lilly and Company, running 9 of these trials.
Enrollment posture brief
Registry condition ulcerative-colitis
OPEN 45 | RECR 37% | LATE 32 | EARLY 47 | RANK #97 | SPON 9
Volume-matched condition peers
Nearest open-share peer: Type 2 Diabetes (37% recruiting · 328 trials)
Ulcerative Colitis lists 45 open slots (37% of 123 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Ulcerative Colitis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Ulcerative Colitis recruits in line with its size-band peers.
45 of 123 indexed trials (36.6%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Ulcerative Colitis trials is spread across many organizations.
Eli Lilly and Company accounts for 9 of 123 trials (7.3%). 72 distinct sponsors appear on at least one study for this condition label.
-
Typical Ulcerative Colitis enrolment sits around 118 participants.
Median target enrolment is 118 among the 123 trials that report a genuine target (sentinel values excluded). 56 of those (45.5%) plan for fewer than 100 participants.
-
Ulcerative Colitis research is mostly interventional.
103 interventional and 20 observational studies make up this index (83.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
123 total, page 3 of 3
Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Takeda
NCT03196427
A Comprehensive Self-Management Intervention for Individuals With Inflammatory Bowel Disease
University of Washington
NCT05651542
Intestinal Ultrasound for the Evaluation of Pouchitis and Other Outcomes After Ileal Pouch-Anal Anastomosis
Mayo Clinic
NCT06316999
Ulcerative Colitis Relapse Prevention Trial, Hypnosis
Northwestern University
NCT00798642
Mind/Body Medicine and IBD Flare-Up
Rush University Medical Center
NCT00568256
A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of rhuMAb Beta7 in Patients With Ulcerative Colitis
Genentech
NCT00694980
SMART-IBD App Trial
Children's Hospital Medical Center, Cincinnati
NCT06023667
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.
Amgen
NCT01290042
Safety, Tolerability, and Pharmacokinetics of Oral NX-13 in Active Ulcerative Colitis
Landos Biopharma
NCT04862741
Efficacy and Safety of Orally Administered BBT-401-1S in Subjects With Ulcerative Colitis
Bridge Biotherapeutics
NCT04596293
Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis
Avaxia Biologics, Incorporated
NCT01759056
Protein Metabolism in Newly Diagnosed Pediatric Inflammatory Bowel Disease
Indiana University
NCT00586352
Transcutaneous VNS to Treat Pediatric IBD
Northwell Health
NCT03863704
Digital Behavioral Interventions in Inflammatory Bowel Disease
Montefiore Medical Center
NCT04861597
Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitis
Harbor Therapeutics
NCT00628433
A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC)
Eli Lilly and Company
NCT04004611
Fecal Transplant for Ulcerative Colitis
University of Minnesota
NCT03948919
A Dose-Escalation Study of MDX-1100 in Patients With Active Ulcerative Colitis
Bristol-Myers Squibb
NCT00295282
Broccoli Sprouts for Mild Ulcerative Colitis
University of Michigan
NCT05507931
Anti-Inflammatory Effects of Mango Polyphenolics in Inflammatory Bowel Disease
Texas A&M University
NCT02227602
Interferon-beta1a (AVONEX) Treatment of Ulcerative Colitis
National Institute of Allergy and Infectious Diseases (NIAID)
NCT00048347
Fecal Microbiota Transplant (FMT) in Pediatric Active Ulcerative Colitis and Pediatric Active Crohn's Colitis
Stacy A. Kahn
NCT02330653
Oral OKT3 for the Treatment of Active Ulcerative Colitis
Brigham and Women's Hospital
NCT01287195
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 15 |
| Phase 2 | 32 |
| Phase 3 | 28 |
| Phase 4 | 4 |
Top Sponsors
Named interventions
Most-linked intervention names on Ulcerative Colitis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Ulcerative Colitis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Ulcerative Colitis page
123 registered trials, 45 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 45 Ulcerative Colitis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Eli Lilly and Company sponsors the most Ulcerative Colitis trials on record, review their full trial history before evaluating a specific study. See Eli Lilly and Company's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Ulcerative Colitis condition card totals 123 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.